ECSP078038A - Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales - Google Patents
Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus salesInfo
- Publication number
- ECSP078038A ECSP078038A EC2007008038A ECSP078038A ECSP078038A EC SP078038 A ECSP078038 A EC SP078038A EC 2007008038 A EC2007008038 A EC 2007008038A EC SP078038 A ECSP078038 A EC SP078038A EC SP078038 A ECSP078038 A EC SP078038A
- Authority
- EC
- Ecuador
- Prior art keywords
- micronized
- chlorophenyl
- salts
- pharmaceutical formulations
- immediate release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a formulaciones farmacéuticas sólidas de liberación inmediata y con una carga elevada de droga que comprenden (4-clorofenil)[4-(4-piridilmetil)-ftalazin-1-ilo] no micronizado, y sales del mismo aceptables para uso farmacéutico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05090166A EP1731153A1 (en) | 2005-06-07 | 2005-06-07 | Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)¬4-(4-pyridylmethyl)phthalazin-1-yl| and salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP078038A true ECSP078038A (es) | 2008-01-23 |
Family
ID=34938467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2007008038A ECSP078038A (es) | 2005-06-07 | 2007-12-19 | Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales |
Country Status (21)
Country | Link |
---|---|
EP (2) | EP1731153A1 (es) |
JP (1) | JP2008542420A (es) |
KR (1) | KR20080031005A (es) |
CN (1) | CN101242840A (es) |
AR (1) | AR053889A1 (es) |
AU (1) | AU2006256852A1 (es) |
BR (1) | BRPI0613393A2 (es) |
CA (1) | CA2610975A1 (es) |
CR (1) | CR9563A (es) |
DO (1) | DOP2006000127A (es) |
EC (1) | ECSP078038A (es) |
GT (1) | GT200600242A (es) |
IL (1) | IL187905A0 (es) |
MX (1) | MX2007015494A (es) |
NO (1) | NO20080065L (es) |
PE (1) | PE20070319A1 (es) |
RU (1) | RU2007147951A (es) |
TW (1) | TW200716115A (es) |
UY (1) | UY29582A1 (es) |
WO (1) | WO2006131393A1 (es) |
ZA (1) | ZA200800112B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1958616A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof |
AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
-
2005
- 2005-06-07 EP EP05090166A patent/EP1731153A1/en not_active Withdrawn
-
2006
- 2006-06-06 TW TW095120062A patent/TW200716115A/zh unknown
- 2006-06-06 RU RU2007147951/15A patent/RU2007147951A/ru not_active Application Discontinuation
- 2006-06-06 GT GT200600242A patent/GT200600242A/es unknown
- 2006-06-06 KR KR1020087000236A patent/KR20080031005A/ko not_active Application Discontinuation
- 2006-06-06 WO PCT/EP2006/005600 patent/WO2006131393A1/en active Application Filing
- 2006-06-06 AU AU2006256852A patent/AU2006256852A1/en not_active Abandoned
- 2006-06-06 JP JP2008515151A patent/JP2008542420A/ja active Pending
- 2006-06-06 EP EP06762010A patent/EP1888072A1/en not_active Withdrawn
- 2006-06-06 BR BRPI0613393-2A patent/BRPI0613393A2/pt not_active IP Right Cessation
- 2006-06-06 PE PE2006000619A patent/PE20070319A1/es not_active Application Discontinuation
- 2006-06-06 CN CNA2006800294742A patent/CN101242840A/zh active Pending
- 2006-06-06 CA CA002610975A patent/CA2610975A1/en not_active Abandoned
- 2006-06-06 MX MX2007015494A patent/MX2007015494A/es not_active Application Discontinuation
- 2006-06-07 DO DO2006000127A patent/DOP2006000127A/es unknown
- 2006-06-07 UY UY29582A patent/UY29582A1/es not_active Application Discontinuation
- 2006-06-07 AR ARP060102363A patent/AR053889A1/es unknown
-
2007
- 2007-12-05 IL IL187905A patent/IL187905A0/en unknown
- 2007-12-06 CR CR9563A patent/CR9563A/es not_active Application Discontinuation
- 2007-12-19 EC EC2007008038A patent/ECSP078038A/es unknown
-
2008
- 2008-01-04 NO NO20080065A patent/NO20080065L/no not_active Application Discontinuation
- 2008-01-04 ZA ZA200800112A patent/ZA200800112B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DOP2006000127A (es) | 2006-12-15 |
JP2008542420A (ja) | 2008-11-27 |
EP1888072A1 (en) | 2008-02-20 |
RU2007147951A (ru) | 2009-07-20 |
IL187905A0 (en) | 2008-03-20 |
EP1731153A1 (en) | 2006-12-13 |
PE20070319A1 (es) | 2007-04-12 |
AU2006256852A1 (en) | 2006-12-14 |
KR20080031005A (ko) | 2008-04-07 |
GT200600242A (es) | 2007-02-09 |
AU2006256852A8 (en) | 2006-12-14 |
CN101242840A (zh) | 2008-08-13 |
CR9563A (es) | 2008-02-20 |
NO20080065L (no) | 2008-03-06 |
BRPI0613393A2 (pt) | 2011-01-11 |
MX2007015494A (es) | 2008-02-22 |
CA2610975A1 (en) | 2006-12-14 |
UY29582A1 (es) | 2007-01-31 |
WO2006131393A1 (en) | 2006-12-14 |
TW200716115A (en) | 2007-05-01 |
AR053889A1 (es) | 2007-05-23 |
ZA200800112B (en) | 2010-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR124134A2 (es) | Formulación de uso tópico para un inhibidor de jak | |
MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
UY31647A1 (es) | Forma de dosificación farmacéutica para la administración oral de inhibidor de tirosina quinasa | |
ECSP10010224A (es) | Formulaciones líquidas de hormona luteinizante (lh). | |
CL2019003619A1 (es) | Preparación sólida para administración oral. | |
SG194756A1 (en) | Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
NI201000172A (es) | Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad. | |
CR20120058A (es) | Composiciones nuevas de 1 - [2 - (2,4-dimetil-fenilsulfanil)-fenil] piperazina | |
CO6321158A2 (es) | Formulacion oral | |
ECSP10010167A (es) | Composiciones oftálmicas novedosas | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
CO6311067A2 (es) | Preparación de comprimido con liberación retardada que contiene polivinilpirrolidonas y principio activo | |
ATE479427T1 (de) | Pharmazeutische zusammensetzung mit candesartan- cilexetil | |
UY33873A (es) | Compuestos de pirazol como antagonistas de crth2 | |
ECSP078037A (es) | Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] micronizado, y sus sales | |
ECSP078038A (es) | Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micronizado, y sus sales | |
CU20070271A7 (es) | Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales | |
DE60312642D1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
CR11306A (es) | Nuevos compuestos farmaceuticos | |
WO2007093168A3 (de) | Schnell freisetzende irbesartan-haltige pharmazeutische zusammensetzung | |
NI201000080A (es) | Ácido 4 - [ 4 - (2 - adamantilcarbamoil) - 5 - tert - butilpirazol - 1 - il] benzoico - 465. | |
TH87914B (th) | สูตรผสมทางเภสัชกรรมที่โหลดยาสูง และปล่อยออกทันที่ของ นอน-ไมโครไนเซด (4-คลอโรเฟนิล)[4-(4-พิริดิลเมธิล)ฟแธเลซิน-1-อิล] และเกลือของสารเหล่านั้น | |
ECSP10010540A (es) | Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad |